These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28646814)

  • 1. Nutritional Management of Metabolic Endotoxemia: A Clinical Review.
    Brown BI
    Altern Ther Health Med; 2017 Jul; 23(4):42-54. PubMed ID: 28646814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
    Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: diet or supplementation for metabolic syndrome prevention?
    Peluso I; Romanelli L; Palmery M
    Int J Food Sci Nutr; 2014 May; 65(3):259-67. PubMed ID: 24467635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment.
    De Filippis A; Ullah H; Baldi A; Dacrema M; Esposito C; Garzarella EU; Santarcangelo C; Tantipongpiradet A; Daglia M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of probiotics and prebiotics with the gut microbiota.
    Ballan R; Battistini C; Xavier-Santos D; Saad SMI
    Prog Mol Biol Transl Sci; 2020; 171():265-300. PubMed ID: 32475525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
    Serban DE
    Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential mechanisms for the emerging link between obesity and increased intestinal permeability.
    Teixeira TF; Collado MC; Ferreira CL; Bressan J; Peluzio Mdo C
    Nutr Res; 2012 Sep; 32(9):637-47. PubMed ID: 23084636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia.
    Moreira AP; Texeira TF; Ferreira AB; Peluzio Mdo C; Alfenas Rde C
    Br J Nutr; 2012 Sep; 108(5):801-9. PubMed ID: 22717075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.
    Fallucca F; Porrata C; Fallucca S; Pianesi M
    Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():48-54. PubMed ID: 24532292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia.
    Kaliannan K; Wang B; Li XY; Kim KJ; Kang JX
    Sci Rep; 2015 Jun; 5():11276. PubMed ID: 26062993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.
    Yoo JY; Kim SS
    Nutrients; 2016 Mar; 8(3):173. PubMed ID: 26999199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
    Escobedo G; López-Ortiz E; Torres-Castro I
    Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
    Patel R; DuPont HL
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics as Complementary Treatment for Metabolic Disorders.
    Le Barz M; Anhê FF; Varin TV; Desjardins Y; Levy E; Roy D; Urdaci MC; Marette A
    Diabetes Metab J; 2015 Aug; 39(4):291-303. PubMed ID: 26301190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.